Century acquired Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM).

Century Therapeutics has bought Empirica to drive development of allogeneic cell therapies against the brain cancer glioblastoma. The induced pluripotent stem cell (IPSC) player, which landed a ...

Empirica Therapeutics, a startup co-founded by Donnelly Centre investigator Jason Moffat has been acquired by Century Therapeutics, a U.S. based company developing off-the-shelf cell therapy products ...